Fundraising Fox
Cytokinetics
NASDAQ: CYTKSouth San Francisco, US · Founded 1998 · 798 employees on LinkedIn · 1 known investors
Find your way into Cytokinetics
Sign up to see every warm intro you have to Cytokinetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytokinetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.
Founders & leadership
Cytokinetics was founded in 1998 by James Spudich, Ronald Vale, and Lawrence S.B. Goldstein.
Board
JS
James Sabry
Investors · 1
Founder mafia
3 people who came through Cytokinetics went on to found or lead other companies.
Frequently asked questions
- What does Cytokinetics do?
- Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.
- Who founded Cytokinetics?
- Cytokinetics was founded by James Spudich, Ronald Vale, Lawrence S.B. Goldstein in 1998.
- Who are Cytokinetics's investors?
- Cytokinetics's investors include Foresite Capital.
- Where is Cytokinetics headquartered?
- Cytokinetics is headquartered in South San Francisco, US.